LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid tumours with NRG1/ERBB gene fusions.

Saved in:
Bibliographic Details
Title: LBA61 First analysis of RAIN-701: Study of tarloxotinib in patients with non-small cell lung cancer (NSCLC) EGFR Exon 20 insertion, HER2-activating mutations & other solid tumours with NRG1/ERBB gene fusions.
Authors: Liu, S.V.1 (AUTHOR), Villaruz, L.C.2 (AUTHOR), Lee, V.H.F.3 (AUTHOR), Zhu, V.W.4 (AUTHOR), Baik, C.S.5 (AUTHOR), Sacher, A.6 (AUTHOR), McCoach, C.E.7 (AUTHOR), Nguyen, D.8 (AUTHOR), Li, J.Y-C.9 (AUTHOR), Pacheco, J.M.10 (AUTHOR), Kim, C.1 (AUTHOR), Burns, T.F.11 (AUTHOR), Schenk, E.L.10 (AUTHOR), Leighl, N.12 (AUTHOR), Tozzi, L.13 (AUTHOR), Camidge, D.R.14 (AUTHOR)
Source: Annals of Oncology. 2020 Supplement 4, Vol. 31, pS1189-S1189. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2020.08.2294